Commercial Opportunities - Marketing Opportunities

Psynova Neurotech is seeking to exploit its portfolio of proprietary biomarkers to address the following market opportunities in Neuropsychiatric disorders:

Tests for diagnosis of patients for a pre-disposition to or with an early form of these disorders;

Prognostic tests for assessing the likely outcome of a therapeutic intervention;

Diagnostic tests for identifying responders to particular treatment regimes and also for stratifying patients into sub-groups for clinical studies;

Tools to increase the effectiveness and efficiency of clinical development programmes;

Re-profiling of current drugs for new uses with Neuropsychiatric disorders; and

Identification of novel targets for new drug discovery programmes and the development of new classes of drugs for effective treatment of Neuropsychiatric disorders.